Blenheim Cdp
Blenheim Cdp: address, phone, fax, email, web site, schedule
Blenheim Cdp
Locality: London
Address: CANTILEVER COURT 212 WANDSWORTH ROAD London SW8 2JU
Phone: +44-1482 7892272
Fax: +44-1482 7892272
E-mail:
Web site:
Director / owner / responsible person Blenheim Cdp: n\a
Schedule:
Find error in description or want add more information on you company? - Contact me!
Blenheim Cdp credits: register number, status, company type, incorporation date
Register number: 01694712
Company type: PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Status: Active
Incorporation date: 26-01-1983
Get full report form global database UK for Blenheim Cdp
Service Blenheim Cdp: HUMAN HEALTH AND SOCIAL WORK ACTIVITIES, Social work activities without accommodation, 88990 - Other social work activities without accommodation n.e.c.
Job on Blenheim Cdp vacancies, practice, working, traineeship, career
In Blenheim Cdp open follow vacancies:
Assistant. 1500 GBP.
Helpdesk. 1500 GBP.
Assistant. 1000 GBP.
Responds for Blenheim Cdp on facebook
Responds about Blenheim Cdp. Add respond for Blenheim Cdp in social networks
Blenheim Cdp on map and Google map and street view
Also view related and similar companies and organisation this bisness category, as Blenheim Cdp: Health Manchester Limited | J G Swarbrick Limited | 20/20 Dental Practice Limited | Alda Med Limited | Twh Residential Home Limited
Blenheim Cdp is a PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital). Company number assigned by Companies House is 01694712. The company was incorporated on Wednesday 26th January 1983, so the company age is 33 years 5 months 7 days. The company registration status is Active. The company Standard Industrial Classification is 88990, so Blenheim Cdp is engaged in Other social work activities without accommodation n.e.c.. Blenheim Cdp register address is CANTILEVER COURT, 212 WANDSWORTH ROAD, London (area code: SW8 2JU). The company changed its name 2 times. On Friday 4th May 2007 the name changed to Community Drug Project.